Related Experiment Video
Updated: Jan 19, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Doxorubicin and cyclophosphamide-induced parotitis: A case report
Andrew Fox-Lewis1, Mohammed Tairab2, Graham Fulton3
1Palliative Care Department, Waikato Hospital, Hamilton, New Zealand.
What Is Known And Objective:
Drug-induced parotitis is a rare adverse drug reaction (ADR). A comprehensive literature review identified only three clearly associated medications: L-asparaginase, clozapine and phenylbutazone.
Case Description:
We describe a novel case of drug-induced parotitis attributed to doxorubicin and cyclophosphamide chemotherapy for breast cancer.
What Is New And Conclusion:
Using general and parotitis-specific tools for assessing the probability of an ADR, we estimate the association of doxorubicin and cyclophosphamide with parotitis in this case as 'probable'. To our knowledge, this represents the first reported case of parotitis attributable to these medications and provides a valuable learning tool for the assessment of previously unrecognized ADRs.
Related Concept Videos
Tonsillitis II: Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Pericarditis I: Introduction
